Print ISSN:-2581-8112

Online ISSN:-2581-9151

CODEN : IIJOAT




Downlaod Files

   


Article Access statistics

Viewed: 877

PDF Downloaded: 206


Efficacy of celecoxib and diclofenac in the pain management of Rheumatoid Arthritis: A Clinical study


Full Text PDF Share on Facebook Share on Twitter


Original Article

Author Details : Kolla Saketh, Y. Thimma Reddy, J. Satyanarayana, Gattu Naresh

Volume : 2, Issue : 1, Year : 2016

Article Page : 13-14


Suggest article by email

Abstract

Background: Rheumatoid arthritis(RA) is a systemic auto-immune disorder, involving inflammation of the joints. Non-Steroidal Anti-inflammatory drugs (NSAIDs) are used to reduce the symptoms RA but the Non- Selective NSAIDs such as diclofenac is associated with significant gastro-intestinal side effects including bleeding, ulceration and perforations. NSAIDs like celecoxib which is selective cyclooxygenase (COX) II inhibitor is used widely in order to reduce the GI toxicity.
Objectives: To compare the efficacy of celecoxib and diclofenac in the pain management of RA.
Methods: 30 RA patients were included in the study. Group A (15 patients) was given celecoxib 100mg twice daily (200mg/day) and Group B(15 patients) was given diclofenac 50mg thrice daily(150mg/day) for 6 weeks. Pain was assessed before the start of medication and at the end of 6 weeks using Visual analogue score (VAS). 
Results: Mean age, mean pre-medication VAS scores in both groups was similar. VAS scores were decreased in both groups at the end of 6 weeks, however VAS scale was more less in Group A when compared with Group B.
Interpretation and conclusions: Celecoxib is more effective when compared with diclofenac in pain management of Rheumatoid arthritis.

Key Words: Rheumatoid Arthritis, Selective COX II inhibitors, NSAIDs, Pain

 



How to cite : Saketh K, Reddy Y T, Satyanarayana J, Naresh G, Efficacy of celecoxib and diclofenac in the pain management of Rheumatoid Arthritis: A Clinical study. IP Int J Orthop Rheumatol 2016;2(1):13-14


Copyright © 2016 by author(s) and IP Int J Orthop Rheumatol. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)